Full article: Diabetes, Obesity and Metabolism DOI: 10.1111/dom.70572 I would value your perspective
Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone released from the K-cells of the small intestines and acts on the pancreas to potentiate GSIS (Miyawaki et al., 1999)
Mahmoud FF, Haines D, Dashti AA, El-Shazly S, Al-Najjar F
So this is a growing threat that I think needs to be monitored closely. If GLP-1s do become prohibited, athletes could theoretically apply for a therapeutic use exemption (TUE), which allows them to take a drug if it is treating a legitimate medical condition, and does not meaningfully enhance their performance
Comprehensive Lab Testing Lab tests through Quest Diagnostics are fully included in your monthly subscription, with no additional fees